China Pharma Holdings, Inc.

8-K Entered a material agreement; Other events Jul 22, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 1, 2026 8-K Entered a material agreement; Unregistered sale of equity Mar 3, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 10, 2026 8-K Shareholder vote results Jan 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Regulation FD disclosure Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Terminated a material agreement Dec 26, 2024 8-K Shareholder vote results Dec 26, 2024 8-K Entered a material agreement Dec 13, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement May 30, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Changed accountants May 8, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Other events Mar 29, 2024 8-K Regulation FD disclosure Feb 23, 2024 8-K Entered a material agreement; Unregistered sale of equity Feb 8, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 21, 2023 8-K Shareholder vote results; Other events Dec 19, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Delisting notice or listing-rule failure Oct 3, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Entered a material agreement Apr 20, 2023 10-K Fiscal year ended 2022-12-31 Mar 30, 2023 8-K Other events Mar 29, 2023 8-K Regulation FD disclosure Feb 24, 2023 8-K Shareholder vote results Dec 30, 2022 8-K Entered a material agreement; Unregistered sale of equity Dec 2, 2022 8-K Delisting notice or listing-rule failure Dec 2, 2022 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Delisting notice or listing-rule failure Sep 30, 2022